Hello, everyone, and how are you today? We are doing just splendidly, thank you, despite the icy frost that has descended on the Pharmalot campus. Our solution for such chilly moments is, not surprisingly, to fire up the coffee kettle and indulge ourselves with a few cups of stimulation. Our choice today is blueberry cobbler, should you need some inspiration. By the way, we apologize for the slow posting pace, but we are immersed in the final stages of a project. But we remain happy to receive saucy tips and secret dossiers. Meanwhile, here are some tidbits. Hope your day is productive.

The Trump administration is moving forward on a plan to allow the importation of cheaper drugs from Canada and other countries, a central plank of its plan to combat prescription costs, STAT writes. The Food and Drug Administration will announce a rule letting states develop plans to import certain prescription drugs from Canada. One rule would let states, wholesalers, or pharmacies apply to import certain drugs from Canada, pending a sign-off from the Department of Health and Human Services. A second would let drug makers import their own products sold in other countries.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy